180 related articles for article (PubMed ID: 19825913)
1. Hyperhomocysteinemia and C677T MTHFR genotype in patients with retinal vein thrombosis.
Sottilotta G; Siboni SM; Latella C; Oriana V; Romeo E; Santoro R; Consonni D; Trapani Lombardo V
Clin Appl Thromb Hemost; 2010 Oct; 16(5):549-53. PubMed ID: 19825913
[TBL] [Abstract][Full Text] [Related]
2. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
Weger M; Stanger O; Deutschmann H; Temmel W; Renner W; Schmut O; Semmelrock J; Haas A
Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):286-90. PubMed ID: 11981642
[TBL] [Abstract][Full Text] [Related]
3. MTHFR C677T mutation in central retinal vein occlusion: a case-control study in Chinese population.
Gao W; Wang YS; Zhang P; Wang HY
Thromb Res; 2008; 121(5):699-703. PubMed ID: 17719079
[TBL] [Abstract][Full Text] [Related]
4. Retinal vein occlusion, homocysteine, and methylene tetrahydrofolate reductase genotype.
McGimpsey SJ; Woodside JV; Bamford L; Gilchrist SE; Graydon R; McKeeman GC; Young IS; Hughes AE; Patterson CC; O'Reilly D; McGibbon D; Chakravarthy U
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4712-6. PubMed ID: 16303969
[TBL] [Abstract][Full Text] [Related]
5. [Hyperhomocysteinemia and deep-vein thrombosis].
Qiu L; Yan SK; Song YH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):706-9. PubMed ID: 14714317
[TBL] [Abstract][Full Text] [Related]
6. Further evidence that hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T and A1289C polymorphisms are not risk factors for schizophrenia.
Vilella E; Virgos C; Murphy M; Martorell L; Valero J; Simó JM; Joven J; Fernández-Ballart J; Labad A
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Sep; 29(7):1169-74. PubMed ID: 16076517
[TBL] [Abstract][Full Text] [Related]
7. Hyperhomocysteinemia in central retinal vein occlusion in young adults.
Parodi MB; Di Crecchio L
Semin Ophthalmol; 2003 Sep; 18(3):154-9. PubMed ID: 15513477
[TBL] [Abstract][Full Text] [Related]
8. Plasma homocysteine levels, methylene tetrahydrofolate reductase A1298C gene polymorphism and risk of retinal vein thrombosis.
Ghaznavi H; Soheili Z; Samiei S; Soltanpour MS
Blood Coagul Fibrinolysis; 2016 Sep; 27(6):679-83. PubMed ID: 26650461
[TBL] [Abstract][Full Text] [Related]
9. Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion.
Marcucci R; Giusti B; Betti I; Evangelisti L; Fedi S; Sodi A; Cappelli S; Menchini U; Abbate R; Prisco D
Thromb Res; 2003 Apr; 110(1):7-12. PubMed ID: 12877902
[TBL] [Abstract][Full Text] [Related]
10. Methylenetetrahydrofolate reductase (C677T and A1298C) polymorphisms, hyperhomocysteinemia, and ischemic stroke in Tunisian patients.
Fekih-Mrissa N; Mrad M; Klai S; Mansour M; Nsiri B; Gritli N; Mrissa R
J Stroke Cerebrovasc Dis; 2013 May; 22(4):465-9. PubMed ID: 23642756
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia, C677T MTHFR polymorphism and ischemic stroke in Tunisian patients.
Salem-Berrabah OB; Mrissa R; Machghoul S; Hamida AB; N'siri B; Mazigh C; Aouni Z; Louati I; Layouni S; El Oudi M; Fekih-Mrissa N; Gritli N
Tunis Med; 2010 Sep; 88(9):655-9. PubMed ID: 20812180
[TBL] [Abstract][Full Text] [Related]
12. Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion.
Di Crecchio L; Parodi MB; Sanguinetti G; Iacono P; Ravalico G
Ophthalmology; 2004 May; 111(5):940-5. PubMed ID: 15121372
[TBL] [Abstract][Full Text] [Related]
13. Case-control Study of methylenetetrahydrofolate reductase mutations and hyperhomocysteinemia and risk of stroke.
Almawi WY; Khan A; Al-Othman SS; Bakhiet M
J Stroke Cerebrovasc Dis; 2009; 18(5):407-8. PubMed ID: 19717029
[TBL] [Abstract][Full Text] [Related]
14. Methylenetetrahydrofolate reductase C677T polymorphism in Iraqi patients with ischemic stroke.
Al-Allawi NA; Avo AS; Jubrael JM
Neurol India; 2009; 57(5):631-5. PubMed ID: 19934565
[TBL] [Abstract][Full Text] [Related]
15. Hyperhomocysteinaemia in a young woman presenting with stroke, associated with methylene tetrahydrofolate reductase C677T homozygosity.
Saldana Chaparro R; Barron JL
Ann Clin Biochem; 2004 May; 41(Pt 3):241-4. PubMed ID: 15117441
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the relationship between C677T variants of methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in children receiving antiepileptic drug therapy.
Vurucu S; Demirkaya E; Kul M; Unay B; Gul D; Akin R; Gokçay E
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):844-8. PubMed ID: 18234410
[TBL] [Abstract][Full Text] [Related]
17. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis.
McGimpsey SJ; Woodside JV; Cardwell C; Cahill M; Chakravarthy U
Ophthalmology; 2009 Sep; 116(9):1778-1787.e1. PubMed ID: 19729099
[TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase gene polymorphism and childhood stroke.
Morita DC; Donaldson A; Butterfield RJ; Benedict SL; Bale JF
Pediatr Neurol; 2009 Oct; 41(4):247-9. PubMed ID: 19748043
[TBL] [Abstract][Full Text] [Related]
20. The C677T polymorphism of the methylenetetrahydrofolate reductase gene is associated with idiopathic ischemic stroke in the young Mexican-Mestizo population.
Isordia-Salas I; Barinagarrementería-Aldatz F; Leaños-Miranda A; Borrayo-Sánchez G; Vela-Ojeda J; García-Chávez J; Ibarra-González I; Majluf-Cruz A
Cerebrovasc Dis; 2010; 29(5):454-9. PubMed ID: 20203488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
